B

Bruker

Manufactures analytical instruments for NMR diagnostics

Projektmanager Real Estate & Facility Management

Full-TimeDeadline 10/1/27
No salary listed
Mid
Fällanden, Switzerland
HybridTwo days per week may be worked from home.
Facilities OperationsFacilities Management

About the job

Requirements
  • Approximately 3–5 years of professional experience in facility management, building services engineering, or technical project management.
  • Strong knowledge of building services engineering, including HVAC/plumbing and/or electrical systems.
  • Experience leading projects with responsibility for budgets, schedules, and quality.
  • Experience collaborating with internal stakeholders and external service providers.
  • Knowledge of energy management and an interest in sustainable energy-efficiency solutions.
  • Native-level German and English proficiency at least at B2 level.
  • Ability to work independently, in a structured manner, and with a solution-oriented approach.
  • Communication skills, initiative, and assertiveness.
Responsibilities
  • Coordinate technical matters as the primary contact for building services, working with internal departments and external service providers.
  • Ensure compliance with applicable legal requirements and regulations concerning energy and building services.
  • Provide technical guidance to and oversee external service providers, monitoring performance, quality, and satisfaction of internal stakeholders.
  • Lead individual projects operationally from initiation through completion, defining objectives and milestones, planning resources and budgets, coordinating internal and external participants, managing risks, and documenting work.
  • Obtain, review, and prepare quotations and create procurement documentation.
  • Oversee schedules, costs, and quality for ongoing energy and building-services projects, including prioritization, interface management, and reporting to leadership.
  • Approve orders and invoices in SAP workflows and Onventis.
  • Develop and implement measures and strategies to sustainably reduce energy consumption at the site.
  • Take technical responsibility for site energy efficiency and compliance with energy standards, and act as the contact for energy audits and reporting.
  • Support the ESG team in developing and implementing environmental and energy-saving measures.
Desired Qualifications
  • Knowledge of relevant legal requirements concerning energy and building services.
  • Experience in procurement and contract management.
  • Knowledge of SAP and/or Onventis.
  • Experience in ESG, sustainability, or environmental management.
  • Experience with energy-related audits and reporting.

About the company

Bruker makes analytical and diagnostic instruments used by researchers and industries. Its products help analyze materials and biological samples to reveal chemical structure, composition, and properties, with notable roots in nuclear magnetic resonance (NMR) technology and a broad portfolio beyond that field. The company works by designing and selling instruments such as analytical tools that collect data from samples (for example, signals from nuclei in NMR or other spectroscopic methods) and provide insights to researchers. Bruker differentiates itself through a long history of developing advanced technologies, a focus on innovation in scientific instrumentation, and a global product range serving life sciences, materials science, and environmental analysis, supported by steady investment in research and development. Its goal is to equip researchers and industries with reliable tools to push the boundaries of what is possible in science and discovery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 28, 2026 timsUltra AIP and timsOmni launches deepen proteomics and oligonucleotide workflows.
  • August 10, 2026 MIMETAS deal expands Bruker into human-relevant drug discovery models.
  • UC Berkeley ordered over $6 million of Bruker NMR systems, delivering 2027 revenue.

What critics are saying

  • Bruker’s first-half 2026 organic revenue declined 0.8%, exposing fragile demand recovery.
  • Academic spending stayed soft in 2026, while tariffs and currency pressured results.
  • If MIMETAS and fusion remain niche, Bruker’s acquisition-heavy strategy destroys capital returns.

What makes Bruker unique

  • Bruker owns timsTOF proteomics, NMR, microscopy, and microphysiological systems under one platform.
  • Bruker’s August 31 XFlash 7200 FIRE raises SEM-EDS throughput beyond conventional detector designs.
  • Bruker’s BEST superconductors supply ITER, Wendelstein 7-X, CERN, and fusion demonstrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Stock Purchase Plan
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Disability Insurance
  • Life Insurance
  • Dental Insurance
  • Flexible Work Hours
  • Employee Discounts

Growth & Insights and Company News

6 month growth

10%

1 year growth

13%

2 year growth

13%
Business Wire
Oct 14th, 2026
Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools...

Financial Times
Sep 28th, 2026
Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research. Sep 28 2026 12:00 BST * MultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP * ProteoScape connects PASEF discovery with rapid prm-PASEF target validation * Spectronaut(R) AI transfer learning accelerates adaptation to new MS capabilities * Guided PASEF EXciD enables high-throughput glycopeptide characterization * Integrated HDX-MS workflows advance protein conformation and interaction studies * timsOmni(TM) enables RNA and DNA top-down structural and native RNA analysis SINGAPORE-(BUSINESS WIRE)-Sep. 28, 2026- At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF discovery with prm-PASEF target validation on the same timsTOF platform. Novel timsOmni and integrated HDX-MS workflows extend structural analysis to glycopeptides, proteins, and nucleic acids.

MarketScreener
Sep 21st, 2026
Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure.

Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure. Published on 09/21/2026 at 09:36 am EDT S&P Capital IQ Bruker Corporation announced a multi-system order from University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz?class instrumentation. The investment is centered on a Bruker AV NEO-X 800 MHz spectrometer equipped with a cryogenically cooled MAS CryoProbe, complemented by several additional NMR systems and upgrades supporting solid-state, solution-state and Dynamic Nuclear Polarization (DNP) research. The UC Berkeley NMR order exceeds USD 6 million and is expected to be delivered in 2027. (C) S&P Capital IQ - 2026

U.S. Securities and Exchange Commission
Sep 19th, 2026
10-K

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

U.S. Securities and Exchange Commission
Sep 18th, 2026
10-Q

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023